ASTH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ASTH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-17), the Forward Annual Dividend Yield of Astrana Health is 0.00%.
As of today (2024-05-17), the Trailing Annual Dividend Yield of Astrana Health is 0.00%.
Astrana Health's Dividends per Share for the three months ended in Mar. 2024 was $0.00.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
For the Medical Care Facilities subindustry, Astrana Health's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Astrana Health's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Astrana Health (NAS:ASTH) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.
Thank you for viewing the detailed overview of Astrana Health's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Chandan Basho | officer: See Remarks | 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801 |
John Vong | officer: SVP-Chief Accounting Officer | 4288 BIRCHWOOD AVENUE, SEAL BEACH CA 90740 |
Linda Marsh | director | 100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801 |
Allied Physicians Of California, A Profession Medical Corp | 10 percent owner | 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801 |
Weili Dai, | director | 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801 |
J. Lorraine Estradas | director | 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801 |
David Schmidt | director | 700 N. BRAND BLVD, SUITE 220, GLENDALE CA 91203 |
Albert Waichow Young | officer: Chief Administrative Officer | 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801 |
Adrian Vazquez | officer: Chief Medical Officer | C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801 |
Thomas S. Lam | director, officer: President and Co-CEO | 1668 GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801 |
Kenneth T. Sim | director, officer: Executive Chairman and Co-CEO | 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801 |
Brandon Sim | director, officer: See Remarks | C/O APOLLO MEDICAL HOLDINGS, INC., 1668 S. GARFIELD AVENUE, 3RD FLOOR, ALHAMBRA CA 91801 |
Eric Chin | officer: Chief Financial Officer | 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801 |
Michael F. Eng | director | 712 BATAAN PLACE, MONTEREY PARK CA 91755 |
Hing Ang | officer: Chief Operating Officer | 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801 |
From GuruFocus
By PRNewswire • 01-24-2024
By PRNewswire • 01-24-2024
By PRNewswire • 12-18-2023
By GuruFocus Research • 02-06-2024
By GuruFocus Research • 02-06-2024
By GuruFocus Research • 02-06-2024
By GuruFocus Research • 11-06-2023
By GuruFocus Research • 02-06-2024
By GuruFocus Research • 02-06-2024
By GuruFocus Research • 02-06-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.